Browsing: trades

Novo Nordisk A/S (ISIN DK0062498333) stock is trading close to its recent record highs, supported by strong revenue and profit growth driven by its GLP-1 diabetes and obesity portfolio and reflecting a rising market capitalization well above EUR 500 billion as of mid 2025 according to public market data. The Danish pharmaceutical group is listed…

Amgen Inc. (ISIN US0311621009) stock sits in the large-cap pharma bracket with investors closely watching how recent double-digit revenue growth and the integration of Horizon Therapeutics translate into future earnings power. In 2023 Amgen reported revenue of roughly $28.2 billion, up around 7% from about $26.3 billion in 2022, while the company continued to return…

Novo Nordisk stock is trading close to record territory, supported by strong demand for its GLP-1 diabetes and obesity treatments and robust recent financial results. The Danish pharmaceutical group Novo Nordisk A/S (ISIN DK0062498333) has reported double digit revenue and operating profit growth in its latest full year and interim figures, underpinned by rapid uptake…

Novo Nordisk stock is trading close to record territory, with investors focusing on how sustained demand for its obesity and diabetes drugs is feeding through into revenue and profit growth for the Danish pharmaceutical group (ISIN DK0062498333). According to the companys most recent quarterly report for Q1 2025, Novo Nordisk reported revenue of DKK 108.0…